SCHEMBL1422385

SCHEMBL1422385

Cc1cc(-c2cccc(C(F)(F)F)c2)nc(OC(=O)c2c(C)cc(-c3cccc(C(F)(F)F)c3)[nH]c2=O)c1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.44
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
GAA P10253 1/20 0.43
HPGD P15428 1/20 0.43
XDH P47989 2/20 0.41
MAPT P10636 2/20 0.41
CDC7 O00311 1/20 0.41
LMNA P02545 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KMO O15229 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.39
LDHA P00338 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CTSK P43235 1/20 0.36
SCN2A Q99250 1/20 0.36
DHODH Q02127 2/20 0.36
MAPK14 Q16539 1/20 0.36
CFTR P13569 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1085066 0.83 PIN1 (0.51) PIN1ALDH1A1KDM4EGAAXDH
SCHEMBL1423201 0.82 KDM4E (0.45) PIN1ALDH1A1KDM4EGAAHPGD
SCHEMBL1085072 0.80 GUSB (0.44) PIN1ALDH1A1KDM4EGAAHPGD
SCHEMBL1085196 0.80 KMO (0.50) PIN1ALDH1A1KDM4EXDHMAPT
SCHEMBL1085376 0.76 XDH (0.56) PIN1ALDH1A1KDM4EXDHMAPT
SCHEMBL1085063 0.75 KMO (0.46) PIN1ALDH1A1KDM4EGAAHPGD
SCHEMBL1420936 0.74 KMO (0.53) PIN1ALDH1A1KDM4EXDHMAPT
SCHEMBL1085249 0.71 KMO (0.43) PIN1ALDH1A1KDM4EXDHMAPT
SCHEMBL1085386 0.69 ALDH1A1 (0.57) ALDH1A1KDM4EGAAHPGDXDH
SCHEMBL1421332 0.69 MAPT (0.51) PIN1ALDH1A1KDM4EGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8227613-B2 Heteroaryl carboxamide derivatives HOFFMANN-LA ROCHE INC. (US) 2012-07-24 US disclosed
EP-2297137-A1 NOVEL HETEROARYL CARBOXAMIDE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2011-03-23 EP disclosed
US-20090318467-A1 NOVEL HETEROARYL CARBOXAMIDE DERIVATIVES HOFFMANN-LA ROCHE, INC. 2009-12-24 US disclosed
WO-2009153182-A1 NOVEL HETEROARYL CARBOXAMIDE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318467-A1 NOVEL HETEROARYL CARBOXAMIDE DERIVATIVES CCR3, CCR2, CCR1 PIN1 2441/4885ALDH1A1 1982/4885KDM4E 2222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.